|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 379.10 DKK | -0.62% |
|
+9.33% | +16.56% |
| Capitalization | 1,69500Cr 26TCr 23TCr 21TCr 20TCr 37TCr 23,87500Cr 39TCr 2,43000Cr 96TCr 11,42200Cr 99TCr 97TCr 41,87800Cr | P/E ratio 2025 * |
16.5x | P/E ratio 2026 * | 16.8x |
|---|---|---|---|---|---|
| Enterprise value | 1,80000Cr 28TCr 24TCr 22TCr 21TCr 39TCr 25,35200Cr 42TCr 2,58000Cr 1,01400Cr 12,12900Cr 1,05500Cr 1,03300Cr 44,47000Cr | EV / Sales 2025 * |
5.85x | EV / Sales 2026 * | 5.88x |
| Free-Float |
70.25% | Yield 2025 * |
3.05% | Yield 2026 * | 2.99% |
Last Transcript: Novo Nordisk A/S
| 1 day | -0.62% | ||
| 1 week | +9.33% | ||
| Current month | +16.56% | ||
| 1 month | +18.04% | ||
| 3 months | +1.49% | ||
| 6 months | -14.47% | ||
| Current year | +16.56% |
| 1 week | 352.2 |  | 389.8 |
| 1 month | 298.6 | | 389.8 |
| Current year | 327.1 | | 389.8 |
| 1 year | 266.9 | | 675.2 |
| 3 years | 266.9 | | 1,033.2 |
| 5 years | 210.08 | | 1,033.2 |
| 10 years | 109.1 | | 1,033.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 07/08/2025 | |
| Director of Finance/CFO | 55 | 15/02/2018 | |
Martin Lange
CTO | Chief Tech/Sci/R&D Officer | 56 | 07/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kasim Kutay
BRD | Director/Board Member | 61 | 23/03/2017 |
| Director/Board Member | 51 | 22/03/2018 | |
Thomas Rantzau
BRD | Director/Board Member | 54 | 22/03/2018 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.90% | 21.31% | 1,412 M€ | |
| +2.14% | 10.45% | 4 M€ | |
| +0.59% | 5.4% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.62% | +9.33% | -38.17% | -17.02% | 26TCr | |
| +1.64% | +3.79% | +35.55% | +201.01% | 95TCr | |
| +2.61% | +2.65% | +45.17% | +20.53% | 49TCr | |
| -0.02% | -0.05% | +24.52% | +44.58% | 39TCr | |
| +0.50% | +5.22% | +29.29% | +18.53% | 36TCr | |
| -0.68% | +5.50% | +30.47% | +23.34% | 30TCr | |
| -1.21% | +1.63% | +8.13% | -2.31% | 27TCr | |
| -0.18% | +4.92% | +25.39% | +35.33% | 27TCr | |
| -0.17% | +1.50% | +20.49% | +20.16% | 18TCr | |
| +1.24% | +3.63% | +36.31% | +43.02% | 15TCr | |
| Average | +0.48% | +2.39% | +21.72% | +38.72% | 36.29TCr | |
| Weighted average by Cap. | +0.89% | +1.40% | +25.74% | +68.06% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 31TCr 4.81TCr 4.12TCr 3.83TCr 3.57TCr 6.67TCr 4,33700Cr 7.16TCr 44TCr 17TCr 2,07500Cr 18TCr 18TCr 7,60700Cr | 31TCr 4.77TCr 4.08TCr 3.8TCr 3.54TCr 6.62TCr 4,29900Cr 7.1TCr 44TCr 17TCr 2,05700Cr 18TCr 18TCr 7,54100Cr |
| Net income | 10TCr 1.61TCr 1.38TCr 1.28TCr 1.2TCr 2.23TCr 1,45200Cr 2.4TCr 15TCr 5.81TCr 69TCr 6.04TCr 5.92TCr 2,54700Cr | 10TCr 1.56TCr 1.34TCr 1.25TCr 1.16TCr 2.17TCr 1,41000Cr 2.33TCr 14TCr 5.64TCr 67TCr 5.87TCr 5.75TCr 2,47300Cr |
| Net Debt | 10TCr 1.64TCr 1.4TCr 1.31TCr 1.22TCr 2.27TCr 1,47800Cr 2.44TCr 15TCr 5.91TCr 71TCr 6.15TCr 6.02TCr 2,59200Cr | 9.93TCr 1.55TCr 1.33TCr 1.24TCr 1.15TCr 2.15TCr 1,39900Cr 2.31TCr 14TCr 5.6TCr 67TCr 5.82TCr 5.7TCr 2,45400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | 379.10 kr | -0.62% | 62,85,013 |
| 09/26/09 | 381.45 kr | +3.00% | 89,47,255 |
| 08/26/08 | 370.35 kr | +1.08% | 60,36,886 |
| 07/26/07 | 366.40 kr | +0.65% | 75,85,852 |
| 06/26/06 | 364.05 kr | +4.99% | 1,27,37,140 |
Delayed Quote Nasdaq Copenhagen, January 12, 2026 at 09:50 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition